Showing results (81-90 of 100) with videos related to
Sort By:
Pageof 10
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 1, 2024
Dysbiosis and diabetic foot ulcers: A metabolic perspective of Staphylococcus aureus infectionRuisi Liu, Jiawei Feng, Yiming Ni, et al.Journal of Cardiac Surgery|May 22, 2010
Resection of an invasive thymoma extending into the superior vena cava and right atriumWeidong Li, Xin Chen, Xiayi Lv, et al.Cell & Bioscience|July 16, 2021
YTHDF2 alleviates cardiac hypertrophy via regulating Myh7 mRNA decoyHongfei Xu, Zhen Wang, Miao Chen, et al.Frontiers in Immunology|September 4, 2024
Histone modifications and their roles in macrophage-mediated inflammation: a new target for diabetic wound healingJing Wang, Jiawei Feng, Yiming Ni, et al.The Journal of Surgical Research|August 3, 2014
Cardiac hypertrophy and dysfunction induced by overexpression of miR-214 in vivoTao Yang, Haihua Gu, Xiaofan Chen, et al.Medicine|October 15, 2016
Blood conservation strategies in cardiac valve replacement: A retrospective analysis of 1645 patientsJunnan Zheng, Liangwei Chen, Linfeng Qian, et al.American Journal of Translational Research|March 25, 2017
MicroRNA-9 regulates non-small cell lung cancer cell invasion and migration by targeting eukaryotic translation initiation factor 5A2Guodong Xu, Guofeng Shao, Qiaoling Pan, et al.Current Molecular Pharmacology|November 8, 2023
Dual Role of Pregnane X Receptor in Nonalcoholic Fatty Liver DiseaseYuan Xu, Ziming An, Shufei Wang, et al.Frontiers in Endocrinology|October 30, 2023
Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipidsYiming Ni, Xin Wang, Qian Wu, et al.Current Pharmaceutical Design|May 8, 2026
Yinzhilan Formula Ameliorates Healing Delay in Diabetic Ulcer by Inhibiting PARP1 Activation and Regulating Macrophage PolarizationJiawei Feng, Yiming Ni, Wei Zhang, et al.Pageof 10